- Conditions
- Amblyopia
- Interventions
- Perceptual learning, Video Games, Occlusion therapy
- Behavioral
- Lead sponsor
- University of California, Berkeley
- Other
- Eligibility
- 5 Years to 75 Years
- Enrollment
- 50 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2015 – 2022
- U.S. locations
- 1
- States / cities
- Berkeley, California
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results come from ClinicalTrials.gov. When the live registry is unavailable, a clearly labeled stored copy may be shown.
These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 145–168
of 242
matching trials from the live ClinicalTrials.gov search.
- Conditions
- Retinitis Pigmentosa
- Interventions
- CNTO 2476
- Drug
- Lead sponsor
- Centocor, Inc.
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 7 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2007 – 2013
- U.S. locations
- 3
- States / cities
- Miami, Florida • Southwest Portland, Oregon • Dallas, Texas
- Conditions
- Myopia
- Interventions
- NeuroVision's NVC treatment for Low Myopia
- Device
- Lead sponsor
- Ohio State University
- Other
- Eligibility
- 18 Years to 59 Years
- Enrollment
- 2 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2007 – 2009
- U.S. locations
- 1
- States / cities
- Columbus, Ohio
- Conditions
- Amblyopia
- Interventions
- Donepezil, Patching
- Drug · Other
- Lead sponsor
- Boston Children's Hospital
- Other
- Eligibility
- 8 Years and older
- Enrollment
- 18 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2012 – 2021
- U.S. locations
- 3
- States / cities
- Boston, Massachusetts • Waltham, Massachusetts • Weymouth, Massachusetts
- Conditions
- Epiretinal Membrane
- Interventions
- Immediate Vitrectomy, Deferred Vitrectomy
- Procedure
- Lead sponsor
- Jaeb Center for Health Research
- Other
- Eligibility
- 50 Years and older
- Enrollment
- 400 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2022 – 2026
- U.S. locations
- 47
- States / cities
- Scottsdale, Arizona • Glendale, California • Huntington Beach, California + 41 more
- Conditions
- Multiple Sclerosis, Optic Nerve, Neuritis
- Interventions
- Nerispirdine, Placebo
- Drug
- Lead sponsor
- Sanofi
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 31 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2008 – 2009
- U.S. locations
- 1
- States / cities
- Bridgewater, New Jersey
- Conditions
- Alzheimer Disease, Alzheimer Dementia, Frontotemporal Dementia
- Interventions
- Spectral-Domain Optical Coherence Tomography (SD-OCT), Magnetic Resonance Imaging (MRI), Positron Emission Tomography (PET), Comprehensive Ophthalmic Examination, Fundus Photography
- Device · Diagnostic Test
- Lead sponsor
- University of Michigan
- Other
- Eligibility
- 45 Years to 80 Years
- Enrollment
- 16 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2019
- U.S. locations
- 1
- States / cities
- Ann Arbor, Michigan
- Conditions
- Choroidal Melanoma, Indeterminate Lesions
- Interventions
- Standard of Care, AU-011
- Other · Drug
- Lead sponsor
- Aura Biosciences
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 2 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2022 – 2023
- U.S. locations
- 7
- States / cities
- Royal Oak, Michigan • Portland, Oregon • Greenville, South Carolina + 4 more
- Conditions
- Meibomian Gland Dysfunction (MGD)
- Interventions
- Vevye(Cyclosporine 0.1% Ophthalmic Solution)
- Drug
- Lead sponsor
- University of Alabama at Birmingham
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 48 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2026 – 2027
- U.S. locations
- 1
- States / cities
- Birmingham, Alabama
- Conditions
- Meibomian Gland Dysfunction
- Interventions
- Meibomian gland (MG) expression
- Procedure
- Lead sponsor
- University of the Incarnate Word
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 40 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2023
- U.S. locations
- 1
- States / cities
- San Antonio, Texas
- Conditions
- Cataract Senile
- Interventions
- Cataract Surgery
- Device
- Lead sponsor
- Carl Zeiss Meditec, Inc.
- Industry
- Eligibility
- 22 Years to 100 Years
- Enrollment
- 284 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2024 – 2025
- U.S. locations
- 14
- States / cities
- Beverly Hills, California • Northridge, California • Orange, California + 11 more
- Conditions
- Presbyopia
- Interventions
- AcuFocus Corneal Inlay ACI 7000PDT
- Device
- Lead sponsor
- AcuFocus, Inc.
- Industry
- Eligibility
- 45 Years to 60 Years
- Enrollment
- 359 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2008 – 2013
- U.S. locations
- 15
- States / cities
- Fayetteville, Arkansas • Los Angeles, California • Newport Beach, California + 12 more
- Conditions
- Hodgkin Lymphoma
- Interventions
- Neurocognitive Evaluation, Quantitative Brain Imaging, Neurologic Evaluation, Health Questionnaire, Vascular Testing, Cardiopulmonary Exercise Testing, Echocardiography, Pulmonary Function Testing, Serum Biomarkers, Ophthalmology Examination
- Other · Procedure
- Lead sponsor
- St. Jude Children's Research Hospital
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 416 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2013 – 2018
- U.S. locations
- 1
- States / cities
- Memphis, Tennessee
- Conditions
- Glaucoma, Open-Angle
- Interventions
- Standard Automatic Perimetry Humphrey Field Analyzer, visuALL H, iCare Home Tonometer, Spectralis Optical coherence tomography (OCT)
- Diagnostic Test
- Lead sponsor
- Wills Eye
- Other
- Eligibility
- 20 Years to 80 Years
- Enrollment
- 53 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2022 – 2026
- U.S. locations
- 1
- States / cities
- Philadelphia, Pennsylvania
- Conditions
- Non-arteritic Anterior Ischemic Optic Neuropathy (NAION), Trauma, Multiple Sclerosis (MS)
- Interventions
- Transcorneal Electrical Stimulation, Sham
- Device
- Lead sponsor
- Wills Eye
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 97 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2013 – 2017
- U.S. locations
- 1
- States / cities
- Philadelphia, Pennsylvania
- Conditions
- Sarcoid Uveitis
- Interventions
- H.P. Acthar gel
- Drug
- Lead sponsor
- John Huang, MD
- Other
- Eligibility
- Not listed
- Enrollment
- 10 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2018 – 2020
- U.S. locations
- 1
- States / cities
- Hamden, Connecticut
- Conditions
- Visual Acuity
- Interventions
- Bausch + Lomb Ultra® Multifocal for Astigmatism
- Device
- Lead sponsor
- Johnson & Johnson Vision Care, Inc.
- Industry
- Eligibility
- 40 Years to 70 Years
- Enrollment
- 75 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2021 – 2022
- U.S. locations
- 9
- States / cities
- Jacksonville, Florida • Maitland, Florida • Decatur, Georgia + 4 more
- Conditions
- Retinitis Pigmentosa
- Interventions
- human retinal progenitor cells, Mock injection
- Biological · Other
- Lead sponsor
- jCyte, Inc
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 84 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2017 – 2020
- U.S. locations
- 3
- States / cities
- Irvine, California • Los Angeles, California • Boston, Massachusetts
- Conditions
- Macular Edema, Cystoid Macular Edema, Uveal Melanoma, Radiation Maculopathy, Radiation Retinopathy
- Interventions
- Ozurdex, Bevacizumab
- Drug
- Lead sponsor
- Arman Mashayekhi
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 6 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2014 – 2015
- U.S. locations
- 1
- States / cities
- Philadelphia, Pennsylvania
- Conditions
- Macular Degeneration, Geographic Atrophy, Stargardt Disease
- Interventions
- Observational
- Other
- Lead sponsor
- Nanoscope Therapeutics Inc.
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 30 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2025
- U.S. locations
- 1
- States / cities
- Dallas, Texas
- Conditions
- Operative Incision
- Interventions
- FS-LASIK 70 degree side-cut angle, FS-LASIK 110 degree side-cut angle
- Device
- Lead sponsor
- University of Utah
- Other
- Eligibility
- 21 Years and older
- Enrollment
- 115 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2014 – 2019
- U.S. locations
- 1
- States / cities
- Murray, Utah
- Conditions
- Normal Individuals
- Interventions
- No intervention
- Other
- Lead sponsor
- Cathey Norton
- Other
- Eligibility
- 13 Years to 40 Years
- Enrollment
- 42 participants
- Timeline
- 2023 – 2024
- U.S. locations
- 2
- States / cities
- Nashville, Tennessee
- Conditions
- Refractive Error, Cataract, Maculopathy
- Interventions
- Not listed
- Lead sponsor
- Sinclair Technologies, LLC
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 150 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2008 – 2009
- U.S. locations
- 1
- States / cities
- Elkins Park, Pennsylvania
- Conditions
- Aphakia, Cataract
- Interventions
- iSert 251 intraocular lens
- Device
- Lead sponsor
- Hoya Surgical Optics, Inc.
- Industry
- Eligibility
- 50 Years and older
- Enrollment
- 125 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2011 – 2012
- U.S. locations
- 5
- States / cities
- Scottsdale, Arizona • Boynton Beach, Florida • Miami, Florida + 2 more